<DOC>
	<DOCNO>NCT00718939</DOCNO>
	<brief_summary>The CVRx® Rheos® Diastolic Heart Failure Trial prospective , randomize , double blind trial 60 subject conduct five center Europe . All subject follow one year post implant .</brief_summary>
	<brief_title>Rheos® Diastolic Heart Failure Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Diastolic</mesh_term>
	<criteria>Be least 21 year age . Have bilateral carotid bifurcation level mandible . Have leave ventricular ejection fraction ≥ 45 % . Clinical Heart Failure elevate BNP NTProBNP . History suspect baroreflex failure autonomic neuropathy . History symptomatic bradyarrhythmias , pericardial constriction , infiltrative cardiomyopathy , cardiac valvular disease . Organ hematologic transplant . History prior surgery , radiation , stent placement carotid sinus region . History severe chronic kidney disease . Life expectancy less one year .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diastolic Heart Failure</keyword>
	<keyword>Cardiac dysfunction</keyword>
	<keyword>Heart Failure</keyword>
</DOC>